Experimental estimates of the prevalence and duration of long COVID symptoms, and rates of adverse events for hospitalised coronavirus (COVID-19) patients compared with those for matched control patients.

In-depth analysis of Winter Coronavirus (COVID-19) Infection Study data looking at trends in self-reported symptoms of coronavirus (COVID-19), including ongoing symptoms and associated risk factors.

All data relating to “Self-reported long COVID after infection with the Omicron variant in the UK".

According to a survey conducted in the United Kingdom (UK) as of April 2022, 919 thousand people were estimated to be suffering from long COVID-19 with the symptoms of weakness/ tiredness, while 591 thousand people were estimated to experiencing shortness of breath as a part of long COVID symptoms.

Estimates of the prevalence of self-reported long COVID and associated activity limitation using responses collected through face-to-face interviews with study workers only.

According to a survey conducted in the United Kingdom (UK) in April 2022, 4.13 percent of all people aged between 35 and 49 years reported to be suffering from long COVID symptoms, the highest share across all age groups. Furthermore, around 3.7 percent of the population aged 50 to 69 years were estimated to suffer from long COVID. Overall, around 863 thousand people in the UK reported their ability to undertake daily activities and routines was affected a little by long COVID symptoms.

Present state of COVID-19 As of May 2022, over 22 million COVID-19 cases had been reported in the UK. The largest surge of cases was noted over the winter period 2021/22. The incidence of cases in the county since the pandemic began stood at around 32,624 per 100,000 population. Cyprus had the highest incidence of COVID-19 cases among its population in Europe at 75,798 per 100,000 people, followed by a rate of 51,573 in Iceland. Over 175 thousand COVID-19 deaths have been reported in the UK. The deadliest day on record was January 20, 2021, when 1,820 deaths were recorded. In the UK, a COVID-19 death is defined as a person who died within 28 days of a positive test.

Preventing long COVID through vaccination According to the WHO, being fully vaccinated alongside a significant proportion of the population also vaccinated is the best way to avoid the spread of COVID-19 or serious symptoms associated with the virus. It is therefore regarded that receiving a vaccine course as well as subsequent booster vaccines limits the chance of developing long COVID symptoms. As of April 27, 2022, around 53.2 million first doses, 49.7 million second doses, and 39.2 booster doses had been administered in the UK.

According to a survey conducted in the United Kingdom (UK) as of April 2022, 246 thousand people in the South East of England were estimated to be suffering long COVID symptoms, the highest number across the regions in the UK. In the North West of England a further 218 thousand people were estimated to have long COVID.

According to a survey conducted in the United Kingdom (UK) as of January 2022, it was estimated that 510 thousand women and 353 thousand men were suffering from symptoms of long COVID which affected their daily activities a little. Furthermore, an estimated 214 thousand women and 132 thousand men had their day-to-day lives affected a lot by the symptoms of long COVID.

Experimental estimates from three approaches to estimating the percentage of people testing positive for coronavirus (COVID-19) and who experience symptoms four or more weeks after infection, broken down by demographic and viral characteristics, using UK Coronavirus Infection Survey data.

Initial estimates of prevalence of ongoing symptoms following coronavirus (COVID-19) infection in staff and pupils from the COVID-19 Schools Infection Survey across a sample of schools, within selected local authority areas in England. This Schools Infection Survey is jointly led by the London School of Hygiene & Tropical Medicine, Public Health England and the Office for National Statistics.

According to a survey conducted in the United Kingdom (UK) in 2021, out of the 1.8 million people estimated to be suffering from the symptoms of long COVID, 863 thousand people had their ability to undertake daily routine activities affected a little. Furthermore, 346 thousand people had their day-to-day activities affected a great deal by long COVID symptoms.

According to a survey conducted in the United Kingdom (UK) as January 2022, it was estimated 89 thousand people who were hospitalized at the time when they contracted COVID-19 were suffering from long COVID symptoms. Furthermore, around 905 thousand people who were not in contact with the NHS when they tested positive for COVID-19 were estimated to be suffering from long COVID.

The purpose of this dataset is to understand the prevalence of the coronavirus in the UK population, using longitudinal data and including not only cross-sectional data but the inclusion of an antibody test for a sub-sample of people. Demographic information is also included allowing for analyse by different variables to identify patterns and trends.

Participants have three options open to them; can have just have one visit, can have a visit every week for a month or, can have a visit every week for a month and then continue to have visits every month for one year in total from when you joined the study. This is entirely voluntary.

At each visit a field worker conducts a questionnaire, and supervises swab tests. A proportion of visits also include a blood sample being taken. The swab and blood samples are tested at laboratories.

The overall purpose of this study is to understand how many people across the UK have or may already have had the coronavirus. This will help the government manage the pandemic moving forwards.

The COVID-19 Community Infection Survey includes information on: • how many people across England and Wales (extending to Scotland and Northern Ireland) test positive for COVID-19 at a given point in time, regardless of whether they report experiencing symptoms • the average number of new infections per week over the course of the study • the number of people who test positive for antibodies, to indicate how many people are ever likely to have had the virus • key demographic information (sex, age, occupation)

According to a survey conducted in March 2020, 47 percent of respondents in the United Kingdom expected their employer to encourage workers with Coronavirus symptoms to stay at home in response to the COVID-19 outbreak. Although this was the most popular measure, their was also strong support for the cancellation of non-essential meetings (45 percent) and the introduction of remote working (43 percent).

In June 2020, 31 percent of 16 to 39 year olds reported experiencing moderate to severe symptoms of depression, prior to the coronavirus pandemic and subsequent lockdown around 11 percent of those aged between 16 and 39 years reported depression symptoms. Across all adults, signs of depression has more than doubled when compared with before the pandemic. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

With COVID-19 at the forefront, people may not have been aware of the importance of seeking medical help for early signs of cancer or taking up screening, when available, to diagnose cancer sooner. In addition, some people may not have wanted to be referred to a hospital for diagnostic tests due to fear of catching coronavirus in the healthcare setting. COVID-19 may have also affected whether people took part in healthy behaviours that could reduce the chances of getting cancer. These factors may have led to more cancers occurring, and more cancers being diagnosed at a late stage when treatment may be less successful.

To understand peoples experiences and attitudes towards potential symptoms of cancer, their help-seeking behaviours and engagement in prevention behaviours (i.e. smoking, diet, exercise, alcohol consumption) during the pandemic we carried out a large study in adults aged 18+ across the UK. We aimed to include adults from a range of different backgrounds.

Working closely with Cancer Research UK, we carried out an online survey with over 7,500 people to ask about any recent symptoms, cancer screening and health behaviours during the UK lockdown period. Survey questions included the time taken to visit the GP with a range of possible cancer symptoms, attitudes to cancer screening, anxiety about seeking help in the current situation, other barriers to seeking help, health behaviours including smoking, alcohol, diet and physical activity, and preferred ways of receiving public health information. The survey was repeated 6 months later to assess any changes in attitudes.

We also interview 26 people (by telephone) who had taken part in the survey across two timepoints (autumn 2020 and spring 2021) to understand their attitudes and behaviours in more detail and how these changed during the course of the pandemic.

Our study findings have been used to help in rapidly developing clear public health messages to encouraging people to act on the early signs of cancer, take up cancer screening when it became available and engage in healthy behaviours. Results from our study have been used to help to reduce the negative impact of COVID-19 on cancer outcomes in the longer term.

Background: The impact of COVID-19 on the UK public attitude towards cancer and potential cancer symptom help-seeking is likely to be considerable, translating into impact on the NHS from delayed referrals, missed screening and later-stage cancer diagnosis.

Aim: The aim of this study was to generate rapid self-report evidence on public views/responses of the covid-19 pandemic on caner symptoms to support and inform public health interventions with the potential to encourage: 1. timely symptom presentation, 2. engagement with cancer screening services and 3. improve cancer-related health behaviours I the wake of the pandemic.

Design: Prospective mixed-methods cohort study in the UK population.

Methods: During June-August 2020, and again six month later, we will conduct UK-wide online population survey of adults ages 18+. We measured attitudes and behaviour in the domains of 1. cancer symptom presentation, 2. intentions to engage with cancer screening, 3. Engagement in cancer-risk behaviours such as smoking, increased alcohol, poor diet and reduced physical activity. We sampled from established online cohorts (via CRUK and HealthWise Wales), supplemented with social media recruitment. Qualitative interviews were conducted with a sub-sample of survey participants to understand contextual influences on cancer attitudes and behaviours.

In the United Kingdom in April 2020, 28 percent of the surveyed healthcare workers who had not been tested for COVID-19 said they had been told testing was not being offered, while a further 16 percent of the respondents said they did not have enough symptoms to be eligible for testing. The latest number of cases in the UK can be found here. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.